title: Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort.
abstract: Malignant astrocytoma is one of the most deadly primary central nervous system tumors. Although significant progress has been made in understanding the molecular pathways that lead to the development of these tumors in adults, comparatively little analysis has been done in childhood astrocytomas, which are less common and have a more favorable prognosis. Our previous studies of an institutional cohort of children with malignant gliomas suggested the existence of distinct molecular pathways of tumorigenesis in younger versus older children, based on the finding of a high frequency of TP53 mutations in tumors from children >3 years of age at diagnosis, compared with those from younger children. In the current study, the association between TP53 mutations and age was examined in greater detail using the multi-institutional group of children enrolled in Children's Cancer Group Study 945, the largest cohort of childhood high-grade gliomas analyzed to date. Seventy-seven tumors with centrally reviewed diagnoses of anaplastic astrocytoma or glioblastoma multiforme had sufficient archival histopathological material for microdissection-based genotyping. Sections were examined histologically, and topographic targets that contained malignant tissue were isolated by microdissection and subjected to PCR-based amplification and sequencing of TP53 exons 5-8. Twenty-six tumors (33.8%) had mutations in those exons. Mutations were observed in 2 of 17 tumors (11.8%) from children <3 years of age at diagnosis versus 24 of 60 tumors (40%) from older children, a difference that was statistically significant (P = 0.04), in agreement with our previous results. Whereas malignant gliomas in older children have a frequency of mutations comparable to tumors that arise in young adults, those from children <3 years old do not. The association between age and frequency of TP53 mutations among pediatric malignant gliomas indicates the probable existence of two distinct pathways of molecular tumorigenesis in younger versus older children.
authors.affiliation: Department of Neurosurgery, University of Pittsburgh Medical Center and the Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA. Pollaci@chplink.chp.edu
authors.forename: I F
authors.initials: IF
authors.lastname: Pollack
authors.forename: S D
authors.initials: SD
authors.lastname: Finkelstein
authors.forename: J
authors.initials: J
authors.lastname: Burnham
authors.forename: E J
authors.initials: EJ
authors.lastname: Holmes
authors.forename: R L
authors.initials: RL
authors.lastname: Hamilton
authors.forename: A J
authors.initials: AJ
authors.lastname: Yates
authors.forename: J L
authors.initials: JL
authors.lastname: Finlay
authors.forename: R
authors.initials: R
authors.lastname: Sposto
mesh_terms: D000293:Adolescent; D000367:Age Factors; D001254:Astrocytoma / Q000235:genetics* / Q000473:pathology; D001932:Brain Neoplasms / Q000235:genetics* / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D016158:Genes, p53 / Q000235:genetics*; D005909:Glioblastoma / Q000235:genetics* / Q000473:pathology; D006801:Humans; D007223:Infant; D009154:Mutation